Key result
This editorial summarizes multiple studies on antiplatelet and anticoagulant therapies, highlighting that very low dose NOACs were associated with greater thrombosis and death risks compared to regular doses in elderly AF patients.
Design
Editorial
Authors
Loading...
This editorial highlights recent evidence on optimizing antithrombotic therapies, risk stratification, and drug interactions in cardiovascular disease management.
This editorial highlights recent evidence on optimizing antithrombotic therapies, risk stratification, and drug interactions in cardiovascular disease management.
Stefan Agewall (2023) conducted an editorial in Cardiovascular disease. Antiplatelet and anticoagulant treatments was evaluated. This editorial summarizes multiple studies on antiplatelet and anticoagulant therapies, highlighting that very low dose NOACs were associated with greater thrombosis and death risks compared to regular doses in elderly AF patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: